Transaction 3902

Target Company Name Inovio Pharmaceuticals Inc.
Target Country United States of America
Buyer Name/MBO Team/MBI Team ApolloBio Corp.
Buyer Country China
Description Inovio will immediately receive $23 million in upfront payment; an additional $20 million in future regulatory milestone payments and double-digit tiered royalties on future sales.
Tombstone Tombstone20180718 1492 1mstmy4
Industry Sector Healthcare & Pharmaceuticals
Global M&A Offices
Hollyhigh International Capital (Global M&A China)
Global M&A Advisory Advisor to the seller